Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AtriCure, Inc.ATRC · Entity 2704 | Chief Operating Officer | June 30, 2026 | July 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AtriCure, Inc.
Report date June 30, 2026 · Filed July 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 229,867 |
Reported balance
After 2026-06-30 transaction · row 1
1 source rowRow 1 · 2026-06-30 · Grant · Acquired 527 · Balance 229,867 F1: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026. F2: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026.
F2: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 30, 2026 Filed Jul 2, 2026 13:00 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 527 | $23.78 | $12,532.06 |
DisclosureSEC source: 0001565823-26-000006 · wk-form4_1782997211.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,867 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2026. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2026, which is the last trading day of the applicable offering period. The closing price on June 30, 2026, was $27.98. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:52 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 22,948 | $31.26 | $717,354.48 |
DisclosureSEC source: 0001565823-26-000004 · wk-form4_1772574751.xml · nonDerivative · entry 3 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 229,340 F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:52 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 25,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001565823-26-000004 · wk-form4_1772574751.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,288 F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:52 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 42,386 | $0.00 | $0.00 |
DisclosureSEC source: 0001565823-26-000004 · wk-form4_1772574751.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,756 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| December 31, 2025 Filed Jan 2, 2026 13:06 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 257 | $27.37 | $7,034.09 |
DisclosureSEC source: 0001565823-26-000002 · wk-form4_1767359181.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,370 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2025. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2025, which is the first trading day of the applicable offering period. The closing price on July 1, 2025 was $32.20. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 12:49 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 550 | $25.84 | $14,212.00 |
DisclosureSEC source: 0001323885-25-000081 · wk-form4_1751460555.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,113 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2025. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 2, 2025, which is the first trading day of the applicable offering period. The closing price on January 2, 2025 was $30.40. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:01 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 15,050 | $38.74 | $583,037.00 |
DisclosureSEC source: 0001323885-25-000025 · wk-form4_1741125669.xml · nonDerivative · entry 3 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,563 F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:01 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 12,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-25-000025 · wk-form4_1741125669.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,613 F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:01 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 32,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-25-000025 · wk-form4_1741125669.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,493 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:26 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 707 | $19.35 | $13,680.45 |
DisclosureSEC source: 0001323885-24-000101 · wk-form4_1719951964.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,227 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2024. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2024, which is the last trading day of the applicable offering period. The closing price on June 28, 2024 was $22.77. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:44 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 14,596 | $36.28 | $529,542.88 |
DisclosureSEC source: 0001323885-24-000034 · wk-form4_1709675075.xml · nonDerivative · entry 3 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,520 F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:44 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 19,205 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-24-000034 · wk-form4_1709675075.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,116 F2 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had Company performance goals and a service period requirement which were met. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:44 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 37,899 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-24-000034 · wk-form4_1709675075.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,911 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| June 30, 2023 Filed Jul 3, 2023 12:21 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 557 | $38.11 | $21,227.27 |
DisclosureSEC source: 0001323885-23-000087 · wk-form4_1688386874.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,012 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2023. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2023, which is the first trading day of the applicable offering period. The closing price on January 3, 2023 was $44.84. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:15 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 11,687 | $38.81 | $453,572.47 |
DisclosureSEC source: 0001323885-23-000030 · wf-form4_167788171562478.xml · nonDerivative · entry 3 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,455 F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:15 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 27,054 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-23-000030 · wf-form4_167788171562478.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,142 F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:15 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 15,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-23-000030 · wf-form4_167788171562478.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,088 F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met. Read SEC document |
| December 30, 2022 Filed Jan 3, 2023 22:15 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 609 | $34.86 | $21,229.74 |
DisclosureSEC source: 0001323885-23-000006 · wf-form4_167278411246585.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,635 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2022. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2022, which is the first trading day of the applicable offering period. The closing price on July 1, 2022 was $41.01. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:33 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 11,440 | $69.59 | $796,109.60 |
DisclosureSEC source: 0001323885-22-000028 · wf-form4_164634316079039.xml · nonDerivative · entry 3 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,026 F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:33 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 12,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-22-000028 · wf-form4_164634316079039.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,466 F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 21:33 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 13,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001323885-22-000028 · wf-form4_164634316079039.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,893 F1 · price: The Reporting Person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 20:38 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 21,444 | $75.54 | $1,619,879.76 |
DisclosureSEC source: 0001209191-21-056180 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,711 F1 · price: This transaction was executed in multiple trades at prices ranging from $74.91 to $76.06 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 09, 2021 Filed Aug 11, 2021 21:17 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 7,065 | $80.79 | $570,781.35 |
DisclosureSEC source: 0001209191-21-050943 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,155 F1 · price: This transaction was executed in multiple trades at prices ranging from $80.00 to $82.57 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:25 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 19,512 | $66.31 | $1,293,840.72 |
DisclosureSEC source: 0001209191-21-017247 · doc4.xml · nonDerivative · entry 3 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,220 F3 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award or Performance Share Award. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:25 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 13,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017247 · doc4.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,732 F2 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 23:25 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 11,098 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017247 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,537 F1 · price: The Reporting person acquired these shares pursuant to the vesting and release of a Performance Share Award under the AtriCure, Inc. 2014 Equity Incentive Plan. The award had both a Company performance goal and a service period requirement, which were both met. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 14:06 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 14,941 | $60.00 | $896,460.00 |
DisclosureSEC source: 0001209191-21-007656 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,939 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| December 17, 2020 Filed Dec 21, 2020 22:00 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 18,617 | $50.00 | $930,850.00 |
DisclosureSEC source: 0001209191-20-064669 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,880 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 12:23 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 29,161 | $40.09 | $1,169,064.49 |
DisclosureSEC source: 0001209191-20-054589 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,497 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.31 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 21:08 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 20,349 | $38.42 | $781,808.58 |
DisclosureSEC source: 0001209191-20-015087 · doc4.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,658 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 21:08 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 16,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-015087 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,507 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 13:07 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $21.04 | $0.00 |
DisclosureSEC source: 0001209191-20-009054 · doc4.xml · derivative · entry 4 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 50,000 shares Expires 2024-01-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. F4 · derivative.exercise_date: These options were granted on January 24, 2014. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 13:07 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 35,059 | $42.00 | $1,472,478.00 |
DisclosureSEC source: 0001209191-20-009054 · doc4.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,740 F2 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 13:07 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 50,000 | $21.04 | $1,052,000.00 |
DisclosureSEC source: 0001209191-20-009054 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 12:32 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (Right to buy) · Derivative | 37,000 | $0.00 Strike: $6.73 | $0.00 |
DisclosureSEC source: 0001209191-20-005718 · doc4.xml · derivative · entry 4 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,000 shares Expires 2022-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. F4 · derivative.exercise_date: These options were granted on December 27, 2012. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 12:32 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 18,383 | $40.00 | $735,320.00 |
DisclosureSEC source: 0001209191-20-005718 · doc4.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,799 F2 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 12:32 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 37,000 | $6.73 | $249,010.00 |
DisclosureSEC source: 0001209191-20-005718 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 13:47 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionStock Option (Right to buy) · Derivative | 38,000 | $0.00 Strike: $6.73 | $0.00 |
DisclosureSEC source: 0001209191-20-004199 · doc4.xml · derivative · entry 4 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,000 Underlying: Common Stock · 38,000 shares Expires 2022-12-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. F4 · derivative.exercise_date: These options were granted on December 27, 2012. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 13:47 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 15,090 | $38.00 | $573,420.00 |
DisclosureSEC source: 0001209191-20-004199 · doc4.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,182 F2 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 13:47 UTC | AtriCure, Inc. ATRC · Entity 2704 | Exercise / conversionCommon Stock | 38,000 | $6.73 | $255,740.00 |
DisclosureSEC source: 0001209191-20-004199 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,772 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| January 16, 2020 Filed Jan 17, 2020 12:44 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 25,471 | $36.00 | $916,956.00 |
DisclosureSEC source: 0001209191-20-003796 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,272 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| January 14, 2020 Filed Jan 16, 2020 12:31 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 36,363 | $34.00 | $1,236,342.00 |
DisclosureSEC source: 0001209191-20-003569 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,743 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.00 to $34.08 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 26, 2019 Filed Dec 30, 2019 12:46 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 31,440 | $32.00 | $1,006,080.00 |
DisclosureSEC source: 0001209191-19-062053 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,106 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 20:53 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 5,235 | $25.51 | $133,544.85 |
DisclosureSEC source: 0001209191-19-050084 · doc4.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,546 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $25.16 to $25.89 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 20:53 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 43,569 | $25.65 | $1,117,544.85 |
DisclosureSEC source: 0001209191-19-050084 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 208,281 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $25.15 to $25.91 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 06, 2019 Filed Feb 12, 2021 21:35 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 3,500 | $29.25 | $102,375.00 |
DisclosureSEC source: 0001209191-21-010168 · doc4.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Held by spouse Disclosed balance after: 0 F1 · price: This transaction was executed in multiple trades at prices ranging from $29.15 to $29.37 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein. Read SEC document |
| March 06, 2019 Filed Feb 12, 2021 21:35 UTC | AtriCure, Inc. ATRC · Entity 2704 | SaleCommon Stock | 7,500 | $29.25 | $219,375.00 |
DisclosureSEC source: 0001209191-21-010168 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,439 F1 · price: This transaction was executed in multiple trades at prices ranging from $29.15 to $29.37 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 11:11 UTC | AtriCure, Inc. ATRC · Entity 2704 | Tax withholdingCommon Stock | 24,482 | $30.77 | $753,311.14 |
DisclosureSEC source: 0001209191-19-017219 · doc4.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,350 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| March 01, 2019 Filed Mar 6, 2019 11:11 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 17,874 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-017219 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,832 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. One third of the shares will vest annually upon the respective one, two, and three year anniversaries of the date of grant. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 12:52 UTC | AtriCure, Inc. ATRC · Entity 2704 | GrantCommon Stock | 252 | $24.00 | $6,048.00 |
DisclosureSEC source: 0001209191-19-000621 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,958 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2018. F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 2, 2018, which was the first trading day of the applicable offering period. The closing price on July 2, 2018 was $28.24. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.